「ACETYLCHOLINE」の共起表現(1語右で並び替え) - Weblio英語共起表現検索


小窓モード

プレミアム

ログイン
設定

設定

Weblio 辞書 > 英和辞典・和英辞典 > ACETYLCHOLINEの意味・解説 > ACETYLCHOLINEに関連した共起表現

「ACETYLCHOLINE」の共起表現一覧(1語右で並び替え)

該当件数 : 176



hrocyte cholinesterase, or (most formally) acetylcholine acetylhydrolase, found primarily in the bl
cholinesterase functions to deactivate the acetylcholine almost immediately by breaking it down.
ich has a short action time, is similar to acetylcholine and acts as a partial agonist of the nicot
It also increases release of acetylcholine and noradrenaline, and improves memory ret
They are stimulated by muscarine and acetylcholine, and blocked by atropine.
The structure of the binding site for the acetylcholine and nicotine was located at the interface
hances the potassium-stimulated release of acetylcholine and glutamate.
rtant central neurotransmitters, including acetylcholine and glutamate have been reported.
nzyme choline acetyltransferase to produce acetylcholine and a coenzyme a byproduct.
his work on neuromodulators, particularly acetylcholine, and for his computational modelling work
e symptoms of schizophrenia, and increases acetylcholine and glutamate levels in the prefrontal cor
ns that release the transmitter substances acetylcholine and serotonin.
ts primarily as a selective α3β4 nicotinic acetylcholine antagonist, and is even more selective tha
It is therefore classified as an indirect acetylcholine antagonist.
o found to act as selective α3β4 nicotinic acetylcholine antagonists, with little or no effect on N
acetylcholine antagonists.
A receptor is cholinergic if it uses acetylcholine as its neurotransmitter.
For his study of acetylcholine as agent in the chemical transmission of n
erase by phosphorylation, so the action of acetylcholine becomes prolonged, pralidoxime (2-PAM) is
known as muscarinic receptor antagonists - acetylcholine being the neurotransmitter of the parasymp
Unlike acetylcholine, bethanechol is not hydrolyzed by cholines
N) to respond to a neurotransmitter called acetylcholine; BFCN are important for the processes of l
After acetylcholine binding, the receptor undergoes an extensi
With the enzyme inhibited, acetylcholine builds up in the synapse and continues to
All three ACh-inhibiting ( Acetylcholine) chemicals can be found in the leaves, ste
AChE is an enzyme that removes acetylcholine from the synapse after it creates the requ
g further effects to the normal release of acetylcholine from the presynaptic terminal, and therefo
annel superfamily is composed of nicotinic acetylcholine, GABAA, GABAA-ρ, glycine and 5-HT3 recepto
the rate limiting step in the synthesis of acetylcholine; hence, hemicholinium-3 decreases the synt
ssible neurotransmitter substances such as acetylcholine, histamine, substance P, and serotonin.
Acetylcholine hyperpolarizes the sinoatrial node which i
Intake of acetylcholine in axoplasm is prevented and the presynapt
inhibitor which prevents the breakdown of acetylcholine in the synapse.
, the acetylcholinesterase breaks down the acetylcholine in the synaptic cleft in order to allow th
nsmission by interfering with synthesis of acetylcholine in nerve endings.
rgic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease.
It stimulates release of dopamine and acetylcholine in the brain in both rodent and primate mo
AMPA-mediated release of noradrenaline and acetylcholine in the hippocampus and frontal cortex of t
r asystole during Stokes-Adams attacks and acetylcholine injections.
nism of breaking down the neurotransmitter acetylcholine into its constituents, acetate and choline
yze the hydrolysis of the neurotransmitter acetylcholine into choline and acetic acid, a reaction n
Acetylcholine is synthesized from choline and a donated
Acetylcholine is associated with attention, concentratio
If it gets inhibited, acetylcholine is not removed after the stimulation and m
Once this receptor binds acetylcholine, it undergoes an extensive change in confo
ed in animals, and found to increase brain acetylcholine levels and produce nootropic effects, as w
nown to be a partial agonist of muscarinic acetylcholine M1, M2 , M3 receptors and M4, which is bel
act as inhibitors of the neurotransmitter acetylcholine, may provide some relief.
testinal tract by blocking the activity of acetylcholine on cholinergic (or muscarinic) receptors o
by antagonism of the excitatory effects of acetylcholine on the cortex, reduction of locomotor acti
inity for adrenaline, dopamine, muscarinic acetylcholine, or serotonin receptors, or any of the mon
turnover number was 3 x 107 (molecules of acetylcholine) per minute per molecule of enzyme.
erase hence increases the concentration of acetylcholine present).
le to a neuron will decrease the amount of acetylcholine produced.
th the nootropic effect from the increased acetylcholine production cancelled out by the opposite e
acetyltransferase, resulting in increased acetylcholine production.
It is a nicotinic acetylcholine receptor antagonist.
Aceclidine acts as a muscarinic acetylcholine receptor agonist.
also mildly anticholinergic, or muscarinic acetylcholine receptor antagonistic.
It also acts as a nicotinic acetylcholine receptor antagonist.
CHRNA7, coding the neuronal nicotinic acetylcholine receptor alpha7 subunit.
ts mode of action is through the nicotinic acetylcholine receptor where it acts as an analogue of a
An acetylcholine receptor (abbreviated AChR) is an integral
The acetylcholine receptor changes conformation upon acetylc
by this gene is a subunit of the nicotinic acetylcholine receptor (nAchR).
ylphenylpiperazinium (DMPP) is a nicotinic acetylcholine receptor agonist which is selective for th
nt, noncompetitive α3β4 neuronal nicotinic acetylcholine receptor antagonist.
Acetylcholine receptor subunit delta is a protein that i
racetam family, and an antidepressant (M1 acetylcholine receptor agonist).
Acetylcholine receptor subunit beta is a protein that in
ism of action is to bind to the muscarinic acetylcholine receptor M1.
Neuronal acetylcholine receptor subunit alpha-7 is a protein that
Cytisine is a nicotinic acetylcholine receptor agonist, and as a pharmaceutical
Structure of the nicotinic acetylcholine receptor (nAchR: PDB 2BG9) which is very s
Neuronal acetylcholine receptor subunit alpha-2 is a protein that
Neuronal acetylcholine receptor subunit alpha-3 is a protein that
Neuronal acetylcholine receptor subunit alpha-9 is a protein that
d-gated ionic channel family and nicotinic acetylcholine receptor gene superfamily.
Neuronal acetylcholine receptor subunit beta-3 is a protein that
Neuronal acetylcholine receptor subunit alpha-10 also known as ch
lly moderately to highly potent muscarinic acetylcholine receptor (anticholinergic) antagonists as
onist, with specificity for the Muscarinic acetylcholine receptor M2, made it a promising starting
uscle, where it may regulate agrin-induced acetylcholine receptor clustering at the neuromuscular j
inds irreversibly and competitively to the acetylcholine receptor found at the neuromuscular juncti
a selective antagonist of the α7 nicotinic acetylcholine receptor in the brain, and as such has app
The acetylcholine receptor of muscle has 5 subunits of 4 dif
its antihistamine effects, and muscarinic acetylcholine receptor antagonism is responsible for its
Since agrin fragments induce acetylcholine receptor aggregation as well as phosphoryl
The muscle acetylcholine receptor is composed of five subunits: two
-246,708; Lumeron, Memcor) is a muscarinic acetylcholine receptor agonist with reasonable selectivi
amine acts in vitro as a strong muscarinic acetylcholine receptor antagonist (anticholinergic) and
e (WAL-2014) is a non-selective muscarinic acetylcholine receptor agonist which acts as a full agon
d that development of new neural nicotinic acetylcholine receptor agonists will be likely to lead t
as selective potentiator of α4β2 nicotinic acetylcholine receptor responses by using two-electrode
allosteric modulator of neuronal nicotinic acetylcholine receptor with sub-type specificity for het
d-gated ion channels such as the nicotinic acetylcholine receptor and GABAA receptor are composed o
ses the actions of the vagus nerve, blocks acetylcholine receptor sites, and decreases bronchial se
n, adrenenaline, histamine, and muscarinic acetylcholine receptor antagonist, though with weaker an
cking drugs in a long lineage of nicotinic acetylcholine receptor anatagonists synthesized by Mary
The Acetylcholine receptor Pathways
enacin works by blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible f
nicotinic receptor is a type of nicotinic acetylcholine receptor, consisting of the subunit combin
nicotinic receptor is a type of nicotinic acetylcholine receptor, consisting of the subunit combin
the α3β4 receptor, is a type of nicotinic acetylcholine receptor, consisting of α3 and β4 subunits
This gene encodes the beta subunit of the acetylcholine receptor.
osely related by homology to the nicotinic acetylcholine receptor.
, nicotine acts primarily on the nicotinic acetylcholine receptor.
for the α2β2 subtype of neuronal nicotinic acetylcholine receptor.
ect causes "fast channel" behaviour of the acetylcholine receptor.
nicotinic acetylcholine receptors (nAChR, also known as "ionotropi
muscarinic acetylcholine receptors (mAChR, also known as "metabotro
cts of GHB are mediated through muscarinic acetylcholine receptors and can be prevented by prior ad
α-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and
d on its involvement in the aggregation of acetylcholine receptors during synaptogenesis.
Muscarinic acetylcholine receptors belong to a class of metabotropi
function of its competitive antagonism to acetylcholine receptors of the nicotinic type.
inhibition of both α2β2 and α4β2 Nicotinic Acetylcholine Receptors by β-Amyloid (1-42) Peptide .
nergic medication that inhibits muscarinic acetylcholine receptors and thus the parasympathetic ner
ich acts as an agonist at neural nicotinic acetylcholine receptors with high selectivity for the α4
The nicotinic acetylcholine receptors (nAChRs) are members of a superf
hermore selective block of α9α10 nicotinic acetylcholine receptors by the conotoxin RgIA has been s
ceptors with similar potency and nicotinic acetylcholine receptors to a much lesser extent.
hycanthone binds to acetylcholine receptors in the worm and result inincreas
arch to map the distribution of muscarinic acetylcholine receptors in the brain.
n identified as an antagonist of nicotinic acetylcholine receptors (nAChrs) in the muscle and brain
as a mixed agonist-antagonist at nicotinic acetylcholine receptors and an antagonist at μ-opioid re
the H1 receptor (24,000 nM) or muscarinic acetylcholine receptors (11,000 nM), and accordingly lac
nM) > H1 receptor (3,100 nM) > muscarinic acetylcholine receptors (>35,000).
Selective block of α9α10 nicotinic acetylcholine receptors by the conotoxin RgIA has been s
ts on serotonin, histamine, and muscarinic acetylcholine receptors have not been assayed, but uniqu
does not have any effect on the muscarinic acetylcholine receptors (mAChR) located on target organs
ich acts as an agonist at neural nicotinic acetylcholine receptors selective for the α4β2 subtype,
and 18-methoxycoronaridine block nicotinic acetylcholine receptors in the brain and can be used for
that also includes the neuronal nicotinic acetylcholine receptors (nAChRs), and the inhibitory neu
ich acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use
arch to map the distribution of muscarinic acetylcholine receptors in the brain, however this drug
Main article: Muscarinic acetylcholine receptors
ct of the poisoning by blocking muscarinic acetylcholine receptors, which would otherwise be overst
vates, and desensitizes neuronal nicotinic acetylcholine receptors, though at much lower potency in
when the body produces antibodies against acetylcholine receptors, and thus inhibits signal transm
s as a partial agonist at neural nicotinic acetylcholine receptors, binding to both the α3β4 and th
ohol because alcohol potentiates nicotinic acetylcholine receptors, leading to re-sensitization and
ist for the α7 subtype of neural nicotinic acetylcholine receptors, with a high level of brain pene
as a partial agonist at neuronal nicotinic acetylcholine receptors, binding to both the α3β4 and th
receptors, opioid receptors, and nicotinic acetylcholine receptors, but not benzodiazepinergic or m
n including antagonist action at nicotinic acetylcholine receptors, and it has also been shown to r
receptors, histamine receptors, muscarinic acetylcholine receptors, and serotonin receptors.
potent and selective agonist for nicotinic acetylcholine receptors, with twice the potency of nicot
e partial agonist at α4β2 neural nicotinic acetylcholine receptors, acting as an agonist at (α4)2(β
s a mixed agonist-antagonist at muscarinic acetylcholine receptors, being a potent and selective ag
rgic that inhibits the action at nicotinic acetylcholine receptors.
y through dopamine modulation by nicotinic acetylcholine receptors.
t's nervous system by inhibiting nicotinic acetylcholine receptors.
er, α2-adrenergic receptor, and muscarinic acetylcholine receptors.
s as a partial agonist at neural nicotinic acetylcholine receptors.
for the D2, 5-HT2, H1, H2, and muscarinic acetylcholine receptors.
s as a partial agonist at neural nicotinic acetylcholine receptors.
ist for the α7 subtype of neural nicotinic acetylcholine receptors.
ist for the α7 subtype of neural nicotinic acetylcholine receptors.
ist for the α7 subtype of neural nicotinic acetylcholine receptors.
ist for the α7 subtype of neural nicotinic acetylcholine receptors.
lated by nicotinic ligand-gated ionotropic acetylcholine receptors.
eceptors, without affecting the muscarinic acetylcholine receptors.
amine receptors, as well as the muscarinic acetylcholine receptors.
as an antagonist towards various nicotinic acetylcholine receptors.
ny of the TCAs analyzed for the muscarinic acetylcholine receptors.
is of a radiotracer for studying nicotinic acetylcholine receptors: (+/-)-Exo-2-(2-[F-18]fluoro-5-p
It enhances acetylcholine release through indirect activation of the
ins depolarized and unresponsive to normal acetylcholine release.
elease, as well as modulating dopamine and acetylcholine release.
Similarly, acetylcholine released from parasympathetic neurons may
It hydrolyzes acetylcholine to choline and an acetate group.
he NMJ nAChRs by preventing the binding of acetylcholine to its receptor.
Binding of acetylcholine to the N termini of each of the two alpha
ry neurotransmitters such as glutamate and acetylcholine via stimulation of H1 receptors in the cer
stimulation, these nerve branches release acetylcholine, which, in turn causes release of nitric o
                                                                                                   


こんにちは ゲスト さん

ログイン

Weblio会員(無料)になると

会員登録のメリット検索履歴を保存できる!

会員登録のメリット語彙力診断の実施回数増加!

無料会員に登録する
英→日 日→英
こんにちは ゲスト さん

ログイン

Weblio会員(無料)になると

会員登録のメリット検索履歴を保存できる!

会員登録のメリット語彙力診断の実施回数増加!

無料会員に登録する

©2024 GRAS Group, Inc.RSS